Inventor · disambiguated record
David J. Livingston
Also filed as: LIVINGSTON DAVID · LIVINGSTON DAVID J
40 granted patents·14 pending applications·1,572 citations·filing 1994–2025
98Inventor score
Files withVERTEX PHARMA27METRO INT BIOTECH LLC15BATCHELOR MARK JAMES2HOECHST MARION ROUSSEL INC2BEMIS GUY W1
Top patents by PatentIndex Score
54 records- 0197US7772366B2Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2007·Granted Aug 10, 2010·24 cites·10 claims
- 0296US5656627AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted Aug 12, 1997·146 cites·12 claims
- 0395US11878027B2Nicotinamide mononucleotide derivatives and their usesMETRO INT BIOTECH LLC·Filed 2022·Granted Jan 23, 2024·2 cites·13 claims
- 0495US10548913B2Nicotinamide mononucleotide derivatives and their usesMETRO INT BIOTECH LLC·Filed 2018·Granted Feb 4, 2020·18 cites·29 claims
- 0594US10233208B1Crystal forms of beta-nicotinamide mononucleotideMETRO INT BIOTECH LLC·Filed 2018·Granted Mar 19, 2019·14 cites·16 claims
- 0694US9919003B2Nicotinamide mononucleotide derivatives and their usesMETRO INT BIOTECH LLC·Filed 2017·Granted Mar 20, 2018·16 cites·37 claims
- 0794US9855289B2Nicotinamide mononucleotide derivatives and their usesMETRO INT BIOTECH LLC·Filed 2016·Granted Jan 2, 2018·19 cites·35 claims
- 0894US7790713B2Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2007·Granted Sep 7, 2010·24 cites·20 claims
- 0994US7288624B2Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2001·Granted Oct 30, 2007·48 cites·10 claims
- 1094US5847135AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted Dec 8, 1998·159 cites·11 claims
- 1194US5716929AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted Feb 10, 1998·137 cites·59 claims
- 1293US11059847B2Crystal forms of β-nicotinamide mononucleotideMETRO INT BIOTECH LLC·Filed 2019·Granted Jul 13, 2021·9 cites·10 claims
- 1393US6423840B1Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2001·Granted Jul 23, 2002·40 cites·10 claims
- 1492US10392416B2Crystal forms of beta-nicotinamide mononucleotideMETRO INT BIOTECH LLC·Filed 2019·Granted Aug 27, 2019·10 cites·24 claims
- 1592US10392415B2Crystal forms of β-nicotinamide mononucleotideMETRO INT BIOTECH LLC·Filed 2016·Granted Aug 27, 2019·10 cites·17 claims
- 1692US6350741B1Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1999·Granted Feb 26, 2002·112 cites·18 claims
- 1792US6204261B1Inhibitors of interleukin-1β Converting enzyme inhibitorsVERTEX PHARMA·Filed 1996·Granted Mar 20, 2001·80 cites·34 claims
- 1892US5874424AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1996·Granted Feb 23, 1999·141 cites·7 claims
- 1991US8119631B2Inhibitors of interleukin-1β converting enzymeBATCHELOR MARK JAMES·Filed 2010·Granted Feb 21, 2012·24 cites·15 claims
- 2091US6103711AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted Aug 15, 2000·80 cites·13 claims
- 2191US5973111AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1997·Granted Oct 26, 1999·91 cites·14 claims
- 2290US11464796B2Nicotinamide mononucleotide derivatives and their usesMETRO INT BIOTECH LLC·Filed 2019·Granted Oct 11, 2022·6 cites·12 claims
- 2390US6420522B1Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1999·Granted Jul 16, 2002·72 cites·10 claims
- 2487US12485135B2Nicotinamide mononucleotide derivatives and their usesMETRO INT BIOTECH LLC·Filed 2023·Granted Dec 2, 2025·0 cites·12 claims
- 2585US11279727B2Anti-viral compounds and methods of useMETRO INT BIOTECH LLC·Filed 2021·Granted Mar 22, 2022·1 cites·8 claims
- 2685US6258948B1Inhibitors of Interleukin-1β converting enzymeVERTEX PHARMA·Filed 1999·Granted Jul 10, 2001·42 cites·46 claims
- 2783US5856116ACrystal structure and mutants of interleukin-1 beta converting enzymeVERTEX PHARMA·Filed 1995·Granted Jan 5, 1999·43 cites·8 claims
- 2882US5843904AInhibitors of interleukin-1βconverting enzymeVERTEX PHARMA·Filed 1995·Granted Dec 1, 1998·51 cites·19 claims
- 2981US5985863ACompositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitorVERTEX PHARMA·Filed 1996·Granted Nov 16, 1999·64 cites·17 claims
- 3075US12391721B2Crystal forms of beta-nicotinamide mononucleotideMETRO INT BIOTECH LLC·Filed 2025·Granted Aug 19, 2025·0 cites·15 claims
- 3175US2022098229A1Crystal forms of beta-nicotinamide mononucleotideLIVINGSTON DAVID J·Filed 2021·Application pending·0 cites
- 3274US6974809B2Inhibitors of interleukin 1-β converting enzymeVERTEX PHARMA·Filed 2003·Granted Dec 13, 2005·5 cites·13 claims
- 3371US6008217AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted Dec 28, 1999·37 cites·30 claims
- 3469US6573259B2Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 2001·Granted Jun 3, 2003·3 cites·15 claims
- 3567US11878994B1Compositions for treatment of inflammationMETRO INT BIOTECH LLC·Filed 2023·Granted Jan 23, 2024·0 cites·30 claims
- 3663US6162790AInhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1998·Granted Dec 19, 2000·17 cites·16 claims
- 3761US2005143436A1Inhibitors of interleukin-1beta converting enzymeVERTEX PHARMA·Filed 2004·Application pending·0 cites
- 3860US2025066413A1Compositions for treatment of inflammationMETRO INT BIOTECH LLC·Filed 2022·Application pending·0 cites
- 3958US6057119ACrystal structure and mutants of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1995·Granted May 2, 2000·10 cites·7 claims
- 4058US2011015371A1Inhibitors of interleukin-1 beta converting enzymeVERTEX PHARMA·Filed 2010·Application pending·0 cites
- 4157US2023255994A1Treatment of covid-19 and/or acute kidney injuryMETRO INT BIOTECH LLC·Filed 2021·Application pending·0 cites
- 4256US2012238749A1Inhibitors of interleukin-1 beta converting enzymeBEMIS GUY W·Filed 2011·Application pending·0 cites
- 4356US2010159446A1Detection Assays and Use ThereofHAFF LAWRENCE A·Filed 2008·Application pending·0 cites
- 4454US2003225269A1Inhibitors of interleukin-1beta converting enzymeVERTEX PHARMA·Filed 2002·Application pending·0 cites
- 4553US2011059458A1Compositions and methods for catalyzing dna-programmed chemistryHUANG YUMEI·Filed 2009·Application pending·0 cites
- 4648US2006292099A1Treatment of eye disorders with sirtuin modulatorsMILBURN MICHAEL·Filed 2006·Application pending·0 cites
- 4747US6329365B1Inhibitors of interleukin-1β converting enzymeVERTEX PHARMA·Filed 1999·Granted Dec 11, 2001·5 cites·16 claims
- 4845US5763590AIsolation of an Mr 52,000 FK506 binding protein and molecular cloning of a corresponding human cDNAVERTEX PHARMA·Filed 1994·Granted Jun 9, 1998·10 cites·2 claims
- 4945US2010159455A1Receptor family profilingENSEMBLE DISCOVERY·Filed 2007·Application pending·0 cites
- 5037US2012165319A1Inhibitors of interleukin-1 beta converting enzymeBATCHELOR MARK JAMES·Filed 2011·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David J. Livingston files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →